Linden Thomas Advisory Services, LLC

Position in VCEL — Vericel Corp

CIK 1965702 Charlotte, NC

Position in VCEL

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$2,493,708

+$950,771 QoQ

Shares Held

56,051

+16.9% QoQ

Ownership

0.110%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

of 48 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $36,440,714 across 14 Biotechnology names. VCEL ranks #8 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CPRX	Catalyst Pharmaceuticals, Inc.	176,004	$5,531,805
2	INCY	Incyte Corp	46,507	$5,272,033
3	VRTX	Vertex Pharmaceuticals Inc / Ma	8,103	$4,025,003
4	REGN	Regeneron Pharmaceuticals, Inc.	5,106	$3,183,795
5	EXEL	Exelixis, Inc.	57,943	$3,152,678
6	LGND	Ligand Pharmaceuticals Inc	9,935	$3,140,354
7	CORT	Corcept Therapeutics Inc	34,641	$3,012,034
8	VCEL	Vericel Corp This page	56,051	$2,493,708

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,493,708	56,051	+16.9%	Shares	Sole	2026-07-16
2026-03-31	$1,542,937	47,962	+10.8%	Shares	Sole	2026-04-10
2025-12-31	$1,558,476	43,279	-1.2%	Shares	Sole	2026-01-16
2025-09-30	$1,378,102	43,791	+0.3%	Shares	Sole	2025-11-06
2025-06-30	$1,857,690	43,659	-0.5%	Shares	Sole	2025-07-31
2025-03-31	$1,958,773	43,899	+0.3%	Shares	Sole	2025-04-30
2024-12-31	$2,404,014	43,781	+1.1%	Shares	Sole	2025-01-21
2024-09-30	$1,829,087	43,292	+0.7%	Shares	Sole	2024-10-17
2024-06-30	$1,971,968	42,981	+2.6%	Shares	Sole	2024-07-10
2024-03-31	$2,178,389	41,876	+2.9%	Shares	Sole	2024-04-30
2023-12-31	$1,449,362	40,701	-0.0%	Shares	Sole	2024-02-01
2023-09-30	$1,364,431	40,705	+0.3%	Shares	Sole	2023-10-20
2023-06-30	$1,524,928	40,589	—	Shares	Sole	2023-07-27
No filing history on record for this holder in this stock.